Biosplice Therapeutics

Biosplice Therapeutics
Biosplice Therapeutics
Type	Privately held company
Industry	Regenerative medicine
Founded	2008; 18 years ago in San Diego, California, US
Founder	Osman Kibar
Fate	Renamed from Samumed
Headquarters	San Diego, California, US
Website	www.biosplice.com

Biosplice Therapeutics, Inc. (formerly Samumed, LLC) is a private biopharmaceutical company based in San Diego, California. It was founded in 2008 by Osman Kibar.

Samumed's products in development target novel components of the Wnt signaling pathway. The company focuses on potential treatments for several diseases; its osteoarthritis program is its most advanced.

References

↑ "Small-molecule therapeutics using Biosplice Therapeutics". Business Outreach. 2023-08-16. Retrieved 2024-07-06.
↑ "Forbes Profile: Osman Kibar", "Forbes"
↑ Herper, Matthew."Cure Baldness? Heal Arthritis? Erase Wrinkles? An Unknown Billionaire's Quest To Reverse Aging", "Forbes", May 10, 2016
1 2 Ramsey, Lydia. "A $12 billion startup you've probably never heard wants to cure baldness and smooth out your wrinkles", "Business Insider", April 2, 2017
↑ Lee, Yoolim. "Eternal Youth Is the Next Big Bet for Singapore Venture Capitalist", "Bloomberg", February 9, 2017
↑ Jackson, Mandy. "ACR Notebook: Lilly's Baricitinib Differentiates On Pain, Ironwood's Duzallo Progress, Corbus Nears Phase III", "Informa Scrip", November 8, 2017"

This United States corporation or company article is a stub. You can help Wikipedia by adding missing information.

[1] "Small-molecule therapeutics using Biosplice Therapeutics". Business Outreach. 2023-08-16. Retrieved 2024-07-06.

[source4-2] "Forbes Profile: Osman Kibar", "Forbes"

[source1-3] Herper, Matthew."Cure Baldness? Heal Arthritis? Erase Wrinkles? An Unknown Billionaire's Quest To Reverse Aging", "Forbes", May 10, 2016

[source2-4] 1 2 Ramsey, Lydia. "A $12 billion startup you've probably never heard wants to cure baldness and smooth out your wrinkles", "Business Insider", April 2, 2017

[source3-5] Lee, Yoolim. "Eternal Youth Is the Next Big Bet for Singapore Venture Capitalist", "Bloomberg", February 9, 2017

[source5-6] Jackson, Mandy. "ACR Notebook: Lilly's Baricitinib Differentiates On Pain, Ironwood's Duzallo Progress, Corbus Nears Phase III", "Informa Scrip", November 8, 2017"